The decrease in TSC22D3 mRNA and protein levels is associated with an increase in inflammation severity in systemic lupus erythematosus (SLE), ulcerative colitis, psoriasis, and other autoimmune inflammatory diseases [29]. This evidence concerns the gene TSC22D3 and psoriasis.